<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2014.2977</article-id>
<article-id pub-id-type="publisher-id">or-31-03-1079</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Analysis of the <italic>B-RAF</italic><sup>V600E</sup> mutation in cutaneous melanoma patients with occupational sun exposure</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>CANDIDO</surname><given-names>SAVERIO</given-names></name><xref rid="af1-or-31-03-1079" ref-type="aff">1</xref><xref rid="fn1-or-31-03-1079" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>RAPISARDA</surname><given-names>VENERANDO</given-names></name><xref rid="af2-or-31-03-1079" ref-type="aff">2</xref><xref rid="fn1-or-31-03-1079" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>MARCONI</surname><given-names>ANDREA</given-names></name><xref rid="af3-or-31-03-1079" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>MALAPONTE</surname><given-names>GRAZIA</given-names></name><xref rid="af1-or-31-03-1079" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>BEVELACQUA</surname><given-names>VALENTINA</given-names></name><xref rid="af1-or-31-03-1079" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>GANGEMI</surname><given-names>PIETRO</given-names></name><xref rid="af4-or-31-03-1079" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author">
<name><surname>SCALISI</surname><given-names>AURORA</given-names></name><xref rid="af5-or-31-03-1079" ref-type="aff">5</xref></contrib>
<contrib contrib-type="author">
<name><surname>McCUBREY</surname><given-names>JAMES A.</given-names></name><xref rid="af6-or-31-03-1079" ref-type="aff">6</xref></contrib>
<contrib contrib-type="author">
<name><surname>MAESTRO</surname><given-names>ROBERTA</given-names></name><xref rid="af7-or-31-03-1079" ref-type="aff">7</xref></contrib>
<contrib contrib-type="author">
<name><surname>SPANDIDOS</surname><given-names>DEMETRIOS A.</given-names></name><xref rid="af8-or-31-03-1079" ref-type="aff">8</xref></contrib>
<contrib contrib-type="author">
<name><surname>FENGA</surname><given-names>CONCETTINA</given-names></name><xref rid="af3-or-31-03-1079" ref-type="aff">3</xref><xref rid="fn2-or-31-03-1079" ref-type="author-notes">&#x0002A;&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>LIBRA</surname><given-names>MASSIMO</given-names></name><xref rid="af1-or-31-03-1079" ref-type="aff">1</xref><xref rid="fn2-or-31-03-1079" ref-type="author-notes">&#x0002A;&#x0002A;</xref><xref ref-type="corresp" rid="c1-or-31-03-1079"/></contrib></contrib-group>
<aff id="af1-or-31-03-1079">
<label>1</label>Laboratory of Translational Oncology and Functional Genomics, Section of General Pathology and Oncology, Department of Bio-medical Sciences, University of Catania, Catania 95124, Italy</aff>
<aff id="af2-or-31-03-1079">
<label>2</label>Occupational Medicine, Vittorio Emanuele - Policlinico Hospital, University of Catania, Catania 95100, Italy</aff>
<aff id="af3-or-31-03-1079">
<label>3</label>Section of Occupational Medicine, Department of the Environment, Security, Territory, Food and Health Sciences, University of Messina, Messina 98125, Italy</aff>
<aff id="af4-or-31-03-1079">
<label>4</label>Division of Pathology, Vittorio Emanuele - Policlinico Hospital, University of Catania, Catania 95100, Italy</aff>
<aff id="af5-or-31-03-1079">
<label>5</label>Unit of Oncologic Diseases, ASP-Catania, Catania 95100, Italy</aff>
<aff id="af6-or-31-03-1079">
<label>6</label>Department of Microbiology and Immunology, East Carolina University, Greenville, NC, USA</aff>
<aff id="af7-or-31-03-1079">
<label>7</label>Experimental Oncology 1, CRO National Cancer Institute, Aviano, Italy</aff>
<aff id="af8-or-31-03-1079">
<label>8</label>Department of Virology, Medical School, University of Crete, Heraklion 71003, Crete, Greece</aff>
<author-notes>
<corresp id="c1-or-31-03-1079">Correspondence to: Dr Massimo Libra, Department of Bio-medical Sciences, Section of General Pathology and Oncology, Laboratory of Translational Oncology and Functional Genomics, University of Catania, Via Androne 83, 95124 Catania, Italy, E-mail: <email>mlibra@unict.it</email></corresp><fn id="fn1-or-31-03-1079">
<label>&#x0002A;</label>
<p>Contributed equally;</p></fn><fn id="fn2-or-31-03-1079">
<label>&#x0002A;&#x0002A;</label>
<p>Shared senior authorship</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2014</year></pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>01</month>
<year>2014</year></pub-date>
<volume>31</volume>
<issue>3</issue>
<fpage>1079</fpage>
<lpage>1082</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>12</month>
<year>2013</year></date>
<date date-type="accepted">
<day>13</day>
<month>01</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2014, Spandidos Publications</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Sun-exposure is one of the risk factors associated with the development of a cutaneous neoplasm. In melanoma, the Ras-Raf-MEK-ERK (MAPK) signaling pathway is constitutively activated through multiple mechanisms, including <italic>B-RAF</italic> mutation. It has been hypothesized that <italic>B-RAF</italic> mutations in melanocytic lesions arise from DNA damage induced by ultraviolet (UV) radiation. However, it is still discussed if <italic>B-RAF</italic> mutations are associated with melanoma patients exposed to the sun. Therefore, in the present study, the known <italic>B-RAF</italic><sup>V600E</sup> mutation was analysed in melanoma samples from 30 indoor and 38 outdoor workers. <italic>B-RAF</italic><sup>V600E</sup> mutation was detected in 52 and 73&#x00025; of outdoor workers and indoor workers, respectively. Of note, this mutation was identified in 12 of 14 (85&#x00025;) melanoma of the trunk diagnosed in indoor workers and in 9 of 19 (47&#x00025;) samples from outdoor workers (p&#x0003D;0.03). By analyzing melanomas of other body sites, no statistical difference in the frequency of <italic>B-RAF</italic><sup>V600E</sup> mutation was identified between the groups of workers. It appears that the mutation detected among indoor workers may be associated with a recreational or intermittent exposure to the sun, as usually the trunk is a sun-protected body site. Overall, these data indicate that the <italic>B-RAF</italic><sup>V600E</sup> mutation detected in melanoma is not associated with a chronic exposure to the sun. Mutations detected in other genes may also contribute to melanoma development in the subset of patients exposed to UV radiation.</p></abstract>
<kwd-group>
<kwd>occupational sun exposure</kwd>
<kwd>melanoma</kwd>
<kwd><italic>B-RAF</italic><sup>V600E</sup> mutations</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Cutaneous melanoma (CM) is the most aggressive form of skin cancer. Its incidence has increased dramatically worldwide over the last 50 years (<xref rid="b1-or-31-03-1079" ref-type="bibr">1</xref>). In Europe the highest incidence rates have been reported in Scandinavia (ca. 15 cases per 100,000 inhabitants and year) and the lowest in Mediterranean countries (ca. 5&#x02013;7 cases per 100,000 inhabitants and year). In a worldwide comparison, the highest incidence rates have been reported in Australia (40&#x02013;60 cases per 100,000 inhabitants and year) (<xref rid="b2-or-31-03-1079" ref-type="bibr">2</xref>,<xref rid="b3-or-31-03-1079" ref-type="bibr">3</xref>). Epidemiologic studies suggest that melanoma is determined by a complex model of pathways that are activated by many factors including genetic factors, phenotypic characteristics, number of melanocytic nevi, anatomic sites (lower limbs in females, posterior trunk in males), family history of melanoma, and the interplay with environmental factors, in particular for cutaneous melanoma, intense and intermittent exposure to ultraviolet (UV) radiation, represent the main risk factors (<xref rid="b4-or-31-03-1079" ref-type="bibr">4</xref>). It is well-established and recognized that a genetic predisposition exists for the development of melanoma and nevi, especially the clinically atypical variants (<xref rid="b5-or-31-03-1079" ref-type="bibr">5</xref>). CM results from uncontrolled melanocytic proliferation, melanin-producing cells located in the basal layer of the epidermis where they have a protective role against UV radiation for the skin by distributing melanin pigment from melanosomes to keratinocytes (<xref rid="b5-or-31-03-1079" ref-type="bibr">5</xref>). Several studies of outdoor workers have shown an excess risk of melanoma and other skin cancers (<xref rid="b6-or-31-03-1079" ref-type="bibr">6</xref>&#x02013;<xref rid="b10-or-31-03-1079" ref-type="bibr">10</xref>). The UVB component of the solar spectrum is the main source of risk for the development of a cutaneous neoplasm. Moreover, the cumulative lifetime dose of UVB radiation seems to be the most important factor for determining carcinogenic potential (<xref rid="b3-or-31-03-1079" ref-type="bibr">3</xref>). Intense sun exposure leads both to DNA damage and to immunosuppression, which together are held to mediate carcinogenesis, while photo-adaptation is thought to reduce DNA damage (<xref rid="b11-or-31-03-1079" ref-type="bibr">11</xref>). Solar radiation is a highly prevalent occupational exposure in farm, fishery and construction workers, letter carriers, gardeners, lumbermen, skiing instructors and mountain guides (<xref rid="b12-or-31-03-1079" ref-type="bibr">12</xref>). Sun-exposed workers in the EU range from 29&#x00025; in Germany to 51&#x00025; in Greece and 39&#x00025; in Italy (<xref rid="b3-or-31-03-1079" ref-type="bibr">3</xref>).</p>
<p>In melanoma, the Ras-Raf-MEK-ERK (MAPK) signaling pathway is constitutively activated through multiple mechanisms. Mutations of <italic>B-RAF</italic> have been proposed to contribute to melanoma development. V600E accounts for &gt;60&#x00025; of <italic>B-RAF</italic> mutations in melanoma and causes a substantial increase in B-Raf kinase activity (<xref rid="b13-or-31-03-1079" ref-type="bibr">13</xref>). It has been suggested that <italic>B-RAF</italic> mutations in melanocytic lesions arise from DNA damage induced by UV radiation (<xref rid="b14-or-31-03-1079" ref-type="bibr">14</xref>). However, it is still unclear if the <italic>B-RAF</italic><sup>V600E</sup> mutations detected in melanoma patients results from their exposure to the sun. Therefore, the <italic>B-RAF</italic><sup>V600E</sup> mutation was analysed in melanoma samples from patients with indoor and outdoor occupational activity.</p></sec>
<sec sec-type="methods">
<title>Patients and methods</title>
<sec>
<title>Patients</title>
<p>The subjects enrolled in this study included 68 consecutive patients diagnosed with cutaneous melanoma between October 1999 and June 2010. Tumor biopsy-specimens were isolated from 52 males and 16 females having at least 10 years of work history before the diagnosis of melanoma. All melanoma samples were collected by the Department of Bio-medical Sciences, University of Catania, Catania, Italy. The local scientific ethics committee approved all the procedures. The patients provided a written informed consent for the study. Medical files of each patient were analyzed for their occupational activity. Accordingly, patients were divided in two groups on the basis of their indoor or outdoor activity. Thirty-eight patient were outdoor workers, while 30 were indoor workers. In the group of outdoor workers there were: 11 farmers, 14 construction workers, 10 road paving workers, 2 beach attendant and 1 fisher man. In the group of indoor work there were: 11 office workers, 12 teachers, 1 Ph.D. student, 4 factory workers and 2 physicians. The duration of sun exposure for all outdoor workers was estimated as &gt;6 h per day. Clinical patient characteristics are reported in <xref rid="tI-or-31-03-1079" ref-type="table">Table I</xref>. DNA was isolated from each melanoma sample with the QIAgen Tissue kit (Qiagen, Valencia, CA, USA).</p></sec>
<sec>
<title>B-RAF<sup>V600E</sup> mutation analysis</title>
<p>All DNA samples were screened in duplicate for <italic>B-RAF</italic><sup>V600E</sup> mutation within exon 15 as previously described (<xref rid="b15-or-31-03-1079" ref-type="bibr">15</xref>).</p></sec>
<sec>
<title>&#x02018;Cosmic Catalogue of Mutations in Cancer&#x02019; analysis</title>
<p>The website of the &#x02018;Cosmic Catalogue of Mutations in Cancer&#x02019; (<ext-link xlink:href="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/" ext-link-type="uri">http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/</ext-link>) was explored imputing the following key words: &#x02018;<italic>B-RAF</italic><sup>V600E</sup>&#x02019;, &#x02018;melanoma&#x02019;, &#x02018;skin&#x02019;, &#x02018;intermittent sun exposure&#x02019; and &#x02018;chronic sun exposure&#x02019;.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Potential relationships between <italic>B-RAF</italic><sup>V600E</sup> mutation and other patient characteristics were examined by the Chi-square test or Fisher&#x02019;s exact test. A p-value &lt;0.05 by a two tailed test was defined to be statistically significant.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<p>Clinical characteristics of melanoma patients are summarized in <xref rid="tI-or-31-03-1079" ref-type="table">Table I</xref>. No differences in the main pathologic features between outdoor workers and indoor workers were observed except for the gender. The number of male outdoor workers was significantly higher compared to that of indoor workers (89 vs. 60&#x00025;; p&#x0003D;0.004) (<xref rid="tI-or-31-03-1079" ref-type="table">Table I</xref>). <italic>B-RAF</italic><sup>V600E</sup> mutation was detected in 42 of 68 (61&#x00025;) melanoma samples. Specifically, 21 out 42 (50&#x00025;) mutations were observed in melanoma of the trunk, 29&#x00025; in melanoma of the head and neck site and 21&#x00025; of the limbs. <italic>B-RAF</italic><sup>V600E</sup> mutation was detected in 20 of 38 (52&#x00025;) outdoor workers and in 22 of 30 (73&#x00025;) indoor workers. However, this difference was not statistically significant (<xref rid="tII-or-31-03-1079" ref-type="table">Table II</xref>). In <xref rid="tII-or-31-03-1079" ref-type="table">Table II</xref>, the distribution of <italic>B-RAF</italic><sup>V600E</sup> mutation according to the tumor sites in both groups of outdoor and indoor workers is also shown. Notably, <italic>B-RAF</italic><sup>V600E</sup> mutation was detected in 12 of 14 (85&#x00025;) melanoma of the trunk diagnosed in indoor workers; while 47&#x00025; of melanoma samples, occurred in outdoor workers, displayed this mutation in the same site (p&#x0003D;0.03). Similarly, higher number of mutations was observed in melanoma of the head and neck diagnosed among indoor workers when compared with those occurred among outdoor workers (78 vs. 42&#x00025;). However, this difference was not statistically significant. <italic>B-RAF</italic><sup>V600E</sup> mutation was detected in 43&#x00025; of melanoma of the limbs among indoor workers; while 86&#x00025; of mutations were detected in melanoma of the same sites among outdoor workers. No statistical difference was observed (<xref rid="tII-or-31-03-1079" ref-type="table">Table II</xref>).</p>
<p>To investigate whether <italic>B-RAF</italic><sup>V600E</sup> mutations may occur differentially in melanoma patients chronically exposed to sun compared with those intermittently exposed to sun, further studies were performed by analyzing the &#x02018;Cosmic Catalogue of Mutations in Cancer&#x02019;. Higher <italic>B-RAF</italic><sup>V600E</sup> mutation rate was detected in melanoma from patients with an intermittent exposure to sun when compared with those chronically exposed to sun (47 vs. 16&#x00025;; p&lt;0.0001) (<xref rid="tIII-or-31-03-1079" ref-type="table">Table III</xref>).</p></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Risk factors associated with the increased incidence of melanoma are still debated. Genetic behavior and sun exposure represent the main players for cutaneous melanoma development (<xref rid="b5-or-31-03-1079" ref-type="bibr">5</xref>,<xref rid="b16-or-31-03-1079" ref-type="bibr">16</xref>). However, intermittent exposure to UV exposure has been demonstrated to have an increased risk of skin cancer (<xref rid="b17-or-31-03-1079" ref-type="bibr">17</xref>).</p>
<p>In recent years, a growing body of evidence supports a role of MAPK pathway in melanoma cell proliferation and survival (<xref rid="b13-or-31-03-1079" ref-type="bibr">13</xref>,<xref rid="b18-or-31-03-1079" ref-type="bibr">18</xref>). In this disease, the most frequent genetic alteration, which accounts for &gt;60&#x00025; of melanomas is the alteration of <italic>B-RAF</italic>, with a glutamic acid for valine substitution at codon 600 in exon 15 (Val600Glu; <italic>B-RAF</italic><sup>V600E</sup>); this mutation introduces a conformational change in protein structure due to glutamic acid that acts as a phosphomimetic between the Thr598 and Ser601 phosphorylation sites, leading to constitutive activation of the protein with a large increase in the basal kinase activity; the resulting hyperactivity of the MAP kinase pathway promotes tumor development (<xref rid="b13-or-31-03-1079" ref-type="bibr">13</xref>,<xref rid="b18-or-31-03-1079" ref-type="bibr">18</xref>).</p>
<p>To understand whether the B-raf<sup>V600E</sup> mutation is associated to chronic or intermittent sun exposure, in the present study we analyzed this mutation in melanoma from patients with and without occupational sun exposure assuming that indoor workers have an intermittent exposure to the sun. <italic>B-RAF</italic><sup>V600E</sup> was mutated in 20 of 38 (52&#x00025;) outdoor workers and in 22 of 30 (73&#x00025;) indoor workers. Although, no statically significant difference was recorded, these data are in agreement with previous findings by Curtin <italic>et al</italic> (<xref rid="b20-or-31-03-1079" ref-type="bibr">20</xref>) showing that <italic>B-RAF</italic><sup>V600E</sup> mutation is not associated with a chronic sun exposure. Accordingly, most recent data indicated that occupational sun exposure did not increase risk of melanoma (<xref rid="b9-or-31-03-1079" ref-type="bibr">9</xref>,<xref rid="b19-or-31-03-1079" ref-type="bibr">19</xref>).</p>
<p>Our study also analysed the <italic>B-RAF</italic><sup>V600E</sup> mutation according to the tumor site between indoor and outdoor workers. This mutation was detected more frequently in melanoma of the trunk from indoor workers compared with outdoor workers. We can argue that the <italic>B-RAF</italic><sup>V600E</sup> mutation detected among indoor workers may be associated with a recreational or intermittent exposure to the sun, as usually the trunk is a less frequently exposed body site. In fact, it was suggested that chronic exposure to the sun may induce photoadaption with increased melanisation and epidermal thickening (<xref rid="b11-or-31-03-1079" ref-type="bibr">11</xref>). The higher frequency of <italic>B-RAF</italic><sup>V600E</sup> mutation melanoma of the trunk in indoor workers is in line with previous data since this mutation was detected more frequently in melanoma of the trunk (<xref rid="b20-or-31-03-1079" ref-type="bibr">20</xref>,<xref rid="b21-or-31-03-1079" ref-type="bibr">21</xref>). Therefore, we can speculate that the melanocytes of melanoma patients, intermittently exposed to the sun, have an increased susceptibility to proliferate and acquire <italic>B-RAF</italic> mutations. Further analysis were performed by exploring the Cosmic Catalogue of Mutations in Cancer confirming that higher <italic>B-RAF</italic><sup>V600E</sup> mutation rate is observed in melanoma from patients with an intermittent exposure to sun when compared with those chronically exposed to sun (47 vs. 16&#x00025;; p&lt;0.0001). In the study conducted by Whiteman <italic>et al</italic> (<xref rid="b4-or-31-03-1079" ref-type="bibr">4</xref>) it has been shown that patients with chronic sun exposure may preferentially develop melanoma of the head and neck. Similarly, in our series melanoma of the head and neck was diagnosed in 12 outdoor workers and in 9 indoor workers, however, this difference did not reach significance due to the small number of the samples.</p>
<p>Overall, these data support the notion that <italic>B-RAF</italic><sup>V600E</sup> mutation detected in melanoma from outdoor workers is not associated with a chronic exposure to the sun. In contrast, indoor workers, that may be exposed to intermittent sunbathing, are more susceptible to developing a melanoma harboring <italic>B-RAF</italic><sup>V600E</sup> mutation. These findings may have important therapeutic implications as melanoma patients with <italic>B-RAF</italic> mutations may benefits from <italic>B-RAF</italic> inhibition (<xref rid="b18-or-31-03-1079" ref-type="bibr">18</xref>). Indication for a direct UV mutagenic effect in melanoma development remains still controversial as the nucleotide exchange detected in the <italic>B-RAF</italic> gene (T/A) is not classically linked to UV mutagenesis signature attributable to cytidine to thymidine (C&gt;T) transitions. As proposed before, it is possible that B-RAF mutations could arise from error prone replication of UV-damaged DNA (<xref rid="b14-or-31-03-1079" ref-type="bibr">14</xref>). However, a potential mechanism of melanoma development after UV-damage is described in <xref rid="f1-or-31-03-1079" ref-type="fig">Fig. 1</xref>. Mutations detected in other genes may also contribute to melanoma development in a subset of patients exposed to UV radiation (<xref rid="b22-or-31-03-1079" ref-type="bibr">22</xref>).</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was supported in part by a grant from the Italian League Against Cancer (Catania, Italy).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-or-31-03-1079"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Naishadham</surname><given-names>D</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2013</article-title><source>CA Cancer J Clin</source><volume>63</volume><fpage>11</fpage><lpage>30</lpage><year>2013</year></element-citation></ref>
<ref id="b2-or-31-03-1079"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garbe</surname><given-names>C</given-names></name><name><surname>Blum</surname><given-names>A</given-names></name></person-group><article-title>Epidemiology of cutaneous melanoma in Germany and worldwide</article-title><source>Skin Pharmacol Appl Skin Physiol</source><volume>14</volume><fpage>280</fpage><lpage>290</lpage><year>2001</year></element-citation></ref>
<ref id="b3-or-31-03-1079"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000FC;tting</surname><given-names>B</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name></person-group><article-title>UV-induced skin cancer at workplace and evidence-based prevention</article-title><source>Int Arch Occup Environ Health</source><volume>83</volume><fpage>843</fpage><lpage>854</lpage><year>2010</year></element-citation></ref>
<ref id="b4-or-31-03-1079"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiteman</surname><given-names>DC</given-names></name><name><surname>Stickley</surname><given-names>M</given-names></name><name><surname>Watt</surname><given-names>P</given-names></name><name><surname>Hughes</surname><given-names>MC</given-names></name><name><surname>Davis</surname><given-names>MB</given-names></name><name><surname>Green</surname><given-names>AC</given-names></name></person-group><article-title>Anatomic site, sun exposure, and risk of cutaneous melanoma</article-title><source>J Clin Oncol</source><volume>24</volume><fpage>3172</fpage><lpage>3177</lpage><year>2006</year></element-citation></ref>
<ref id="b5-or-31-03-1079"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>JM</given-names></name><name><surname>Velez</surname><given-names>NF</given-names></name><name><surname>Tsao</surname><given-names>H</given-names></name></person-group><article-title>Pathways to melanoma</article-title><source>Semin Cutan Med Surg</source><volume>29</volume><fpage>210</fpage><lpage>217</lpage><year>2010</year></element-citation></ref>
<ref id="b6-or-31-03-1079"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Gomez</surname><given-names>B</given-names></name><name><surname>Poll&#x000E1;n</surname><given-names>M</given-names></name><name><surname>Gustavsson</surname><given-names>P</given-names></name><name><surname>Plato</surname><given-names>N</given-names></name><name><surname>Aragon&#x000E9;s</surname><given-names>N</given-names></name><name><surname>L&#x000F3;pez-Abente</surname><given-names>G</given-names></name></person-group><article-title>Cutaneous melanoma: hints from occupational risks by anatomic site in Swedish men</article-title><source>Occup Environ Med</source><volume>61</volume><fpage>117</fpage><lpage>126</lpage><year>2004</year></element-citation></ref>
<ref id="b7-or-31-03-1079"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouchardy</surname><given-names>C</given-names></name><name><surname>Sch&#x000FC;ler</surname><given-names>G</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cancer risk by occupation and socioeconomic group among men - a study by the Association of Swiss Cancer Registries</article-title><source>Scand J Work Environ Health</source><volume>28</volume><issue>Suppl 1</issue><fpage>1</fpage><lpage>88</lpage><year>2002</year></element-citation></ref>
<ref id="b8-or-31-03-1079"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000E5;kansson</surname><given-names>N</given-names></name><name><surname>Floderus</surname><given-names>B</given-names></name><name><surname>Gustavsson</surname><given-names>P</given-names></name><name><surname>Feychting</surname><given-names>M</given-names></name><name><surname>Hallin</surname><given-names>N</given-names></name></person-group><article-title>Occupational sunlight exposure and cancer incidence among Swedish construction workers</article-title><source>Epidemiology</source><volume>12</volume><fpage>552</fpage><lpage>557</lpage><year>2001</year></element-citation></ref>
<ref id="b9-or-31-03-1079"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton-Bishop</surname><given-names>JA</given-names></name><name><surname>Chang</surname><given-names>YM</given-names></name><name><surname>Elliott</surname><given-names>F</given-names></name><etal/></person-group><article-title>Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate</article-title><source>Eur J Cancer</source><volume>47</volume><fpage>732</fpage><lpage>741</lpage><year>2011</year></element-citation></ref>
<ref id="b10-or-31-03-1079"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YM</given-names></name><name><surname>Barrett</surname><given-names>JH</given-names></name><name><surname>Bishop</surname><given-names>DT</given-names></name><etal/></person-group><article-title>Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls</article-title><source>Int J Epidemiol</source><volume>38</volume><fpage>814</fpage><lpage>830</lpage><year>2009</year></element-citation></ref>
<ref id="b11-or-31-03-1079"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bataille</surname><given-names>V</given-names></name><name><surname>Bykov</surname><given-names>VJ</given-names></name><name><surname>Sasieni</surname><given-names>P</given-names></name><name><surname>Harulow</surname><given-names>S</given-names></name><name><surname>Cuzick</surname><given-names>J</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name></person-group><article-title>Photoadaptation to ultraviolet (UV) radiation in vivo: photoproducts in epidermal cells following UVB therapy for psoriasis</article-title><source>Br J Dermatol</source><volume>143</volume><fpage>477</fpage><lpage>483</lpage><year>2000</year></element-citation></ref>
<ref id="b12-or-31-03-1079"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radespiel-Tr&#x000F6;ger</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Pfahlberg</surname><given-names>A</given-names></name><name><surname>Lausen</surname><given-names>B</given-names></name><name><surname>Uter</surname><given-names>W</given-names></name><name><surname>Gefeller</surname><given-names>O</given-names></name></person-group><article-title>Outdoor work and skin cancer incidence: a registry-based study in Bavaria</article-title><source>Int Arch Occup Environ Health</source><volume>82</volume><fpage>357</fpage><lpage>363</lpage><year>2009</year></element-citation></ref>
<ref id="b13-or-31-03-1079"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>AE</given-names></name><name><surname>Torrisi</surname><given-names>E</given-names></name><name><surname>Bevelacqua</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Melanoma: molecular pathogenesis and emerging target therapies (Review)</article-title><source>Int J Oncol</source><volume>34</volume><fpage>1481</fpage><lpage>1489</lpage><year>2009</year></element-citation></ref>
<ref id="b14-or-31-03-1079"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>NE</given-names></name><name><surname>Berwick</surname><given-names>Mb</given-names></name><name><surname>Cordeiro-Stone</surname><given-names>M</given-names></name></person-group><article-title>Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation?</article-title><source>J Invest Dermatol</source><volume>126</volume><fpage>1693</fpage><lpage>1696</lpage><year>2006</year></element-citation></ref>
<ref id="b15-or-31-03-1079"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Malaponte</surname><given-names>G</given-names></name><name><surname>Navolanic</surname><given-names>PM</given-names></name><name><surname>Gangemi</surname><given-names>P</given-names></name><name><surname>Bevelacqua</surname><given-names>V</given-names></name><name><surname>Proietti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Analysis of BRAF mutation in primary and metastatic melanoma</article-title><source>Cell Cycle</source><volume>4</volume><fpage>1382</fpage><lpage>1384</lpage><year>2005</year></element-citation></ref>
<ref id="b16-or-31-03-1079"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrest</surname><given-names>BA</given-names></name><name><surname>Eller</surname><given-names>MS</given-names></name><name><surname>Geller</surname><given-names>AC</given-names></name><name><surname>Yaar</surname><given-names>M</given-names></name></person-group><article-title>The pathogenesis of melanoma induced by ultraviolet radiation</article-title><source>N Engl J Med</source><volume>340</volume><fpage>1341</fpage><lpage>1348</lpage><year>1999</year></element-citation></ref>
<ref id="b17-or-31-03-1079"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandini</surname><given-names>S</given-names></name><name><surname>Sera</surname><given-names>F</given-names></name><name><surname>Cattaruzza</surname><given-names>MS</given-names></name><name><surname>Pasquini</surname><given-names>P</given-names></name><name><surname>Picconi</surname><given-names>O</given-names></name><name><surname>Boyle</surname><given-names>P</given-names></name><name><surname>Melchi</surname><given-names>CF</given-names></name></person-group><article-title>Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure</article-title><source>Eur J Cancer</source><volume>41</volume><fpage>45</fpage><lpage>60</lpage><year>2005</year></element-citation></ref>
<ref id="b18-or-31-03-1079"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maira</surname><given-names>F</given-names></name><name><surname>Catania</surname><given-names>A</given-names></name><name><surname>Candido</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>AE</given-names></name><name><surname>McCubrey</surname><given-names>JA</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Malaponte</surname><given-names>G</given-names></name><name><surname>Fenga</surname><given-names>C</given-names></name></person-group><article-title>Molecular targeted therapy in melanoma: a way to reverse resistance to conventional drugs</article-title><source>Curr Drug Deliv</source><volume>9</volume><fpage>17</fpage><lpage>29</lpage><year>2012</year></element-citation></ref>
<ref id="b19-or-31-03-1079"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuong</surname><given-names>K</given-names></name><name><surname>McGeechan</surname><given-names>K</given-names></name><name><surname>Armstrong</surname><given-names>BK</given-names></name></person-group><collab>AMFS Investigators; GEM Investigators</collab><person-group person-group-type="author"><name><surname>Cust</surname><given-names>AE</given-names></name></person-group><article-title>Occupational sun exposure and risk of melanoma according to anatomical site</article-title><source>Int J Cancer</source><month>Nov</month><day>13</day><year>2013</year><comment>(Epub ahead of print)</comment><pub-id pub-id-type="doi">10.1002/ijc.28603</pub-id></element-citation></ref>
<ref id="b20-or-31-03-1079"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtin</surname><given-names>JA</given-names></name><name><surname>Fridlyand</surname><given-names>J</given-names></name><name><surname>Kageshita</surname><given-names>T</given-names></name><etal/></person-group><article-title>Distinct sets of genetic alterations in melanoma</article-title><source>N Engl J Med</source><volume>353</volume><fpage>2135</fpage><lpage>2147</lpage><year>2005</year></element-citation></ref>
<ref id="b21-or-31-03-1079"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deichmann</surname><given-names>M</given-names></name><name><surname>Krahl</surname><given-names>D</given-names></name><name><surname>Thome</surname><given-names>M</given-names></name><name><surname>W&#x000FC;st</surname><given-names>K</given-names></name><name><surname>Hassanzadeh</surname><given-names>J</given-names></name><name><surname>Helmke</surname><given-names>B</given-names></name></person-group><article-title>The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites</article-title><source>Int J Oncol</source><volume>29</volume><fpage>139</fpage><lpage>145</lpage><year>2006</year></element-citation></ref>
<ref id="b22-or-31-03-1079"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodis</surname><given-names>E</given-names></name><name><surname>Watson</surname><given-names>IR</given-names></name><name><surname>Kryukov</surname><given-names>GV</given-names></name><etal/></person-group><article-title>A landscape of driver mutations in melanoma</article-title><source>Cell</source><volume>150</volume><fpage>251</fpage><lpage>263</lpage><year>2012</year></element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figure and Tables</title>
<fig id="f1-or-31-03-1079" position="float">
<label>Figure 1</label>
<caption>
<p>Potential mechanism of melanoma development and progression after UV-damage. UVA, Ultraviolet A; UVB, ultraviolet B; CPDs, cyclobutane pyrimidine dimers; Fapy, formamidopyrimidines; 8-oxo-dG, 8-Oxo-2&#x02032;-deoxyguanosine; G^T, guanine to thymidine transversion; <italic>B-RAF</italic>, v-raf murine sarcoma viral oncogene homolog B; CDKN2A, cyclin-dependent kinase inhibitor 2A; NRAS, neuroblastoma RAS viral (v-ras) oncogene homolog; PTEN, phosphatase and tensin homolog; TP53, tumor protein p53; PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit &#x003B1;; MITF, microphthalmia-associated transcription factor; APAF-1, apoptotic peptidase activating factor 1; AKT3, v-akt murine thymoma viral oncogene homolog 3.</p></caption>
<graphic xlink:href="OR-31-03-1079-g00.gif"/></fig>
<table-wrap id="tI-or-31-03-1079" position="float">
<label>Table I</label>
<caption>
<p>Clinical characteristics of melanoma patients.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Clinical features</th>
<th align="center" valign="bottom">Outdoor (38)<break/>n (&#x00025;)</th>
<th align="center" valign="bottom">Indoor (30)<break/>n (&#x00025;)</th>
<th align="center" valign="bottom">P-value</th></tr></thead>
<tbody>
<tr>
<td colspan="4" align="left" valign="top">Gender</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Male</td>
<td align="center" valign="top">34 (89)</td>
<td align="right" valign="top">18 (60)</td>
<td align="center" valign="top">0.004</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Female</td>
<td align="center" valign="top">4 (11)</td>
<td align="right" valign="top">12 (40)</td>
<td align="center" valign="top"/></tr>
<tr>
<td colspan="4" align="left" valign="top">Age</td></tr>
<tr>
<td align="left" valign="top">&#x02003;&#x02264;55</td>
<td align="center" valign="top">21 (55)</td>
<td align="right" valign="top">16 (53)</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">&#x02003;&gt;55</td>
<td align="center" valign="top">17 (45)</td>
<td align="right" valign="top">14 (47)</td>
<td align="center" valign="top"/></tr>
<tr>
<td colspan="4" align="left" valign="top">Tumor type</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Primary melanoma</td>
<td align="center" valign="top">25 (66)</td>
<td align="right" valign="top">18 (60)</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Metastatic melanoma</td>
<td align="center" valign="top">13 (34)</td>
<td align="right" valign="top">12 (40)</td>
<td align="center" valign="top"/></tr>
<tr>
<td colspan="4" align="left" valign="top">Clark&#x02019;s level</td></tr>
<tr>
<td align="left" valign="top">&#x02003;III</td>
<td align="center" valign="top">13 (34)</td>
<td align="right" valign="top">13 (43)</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">&#x02003;IV</td>
<td align="center" valign="top">11 (29)</td>
<td align="right" valign="top">17 (57)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">&#x02003;V</td>
<td align="center" valign="top">1 (3)</td>
<td align="right" valign="top">-</td>
<td align="center" valign="top"/></tr>
<tr>
<td colspan="4" align="left" valign="top">Breslow thickness</td></tr>
<tr>
<td align="left" valign="top">&#x02003;&#x02264;2.00 mm</td>
<td align="center" valign="top">13 (34)</td>
<td align="right" valign="top">10 (33)</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">&#x02003;2.01&#x02013;5.00 mm</td>
<td align="center" valign="top">14 (37)</td>
<td align="right" valign="top">10 (33)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">&#x02003;&#x02265;5.00 mm</td>
<td align="center" valign="top">11 (29)</td>
<td align="right" valign="top">10 (33)</td>
<td align="center" valign="top"/></tr>
<tr>
<td colspan="4" align="left" valign="top">Tumor site</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Trunk</td>
<td align="center" valign="top">19 (50)</td>
<td align="right" valign="top">14 (47)</td>
<td align="center" valign="top">NS</td></tr>
<tr>
<td align="left" valign="top">&#x02003;Head and Neck<xref rid="tfn1-or-31-03-1079" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">12 (32)</td>
<td align="right" valign="top">9 (30)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">&#x02003;Limbs</td>
<td align="center" valign="top">7 (18)</td>
<td align="right" valign="top">7 (23)</td>
<td align="center" valign="top"/></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-or-31-03-1079">
<label>a</label>
<p>Including nose and scalp. NS, not significant.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="tII-or-31-03-1079" position="float">
<label>Table II</label>
<caption>
<p>Distribution of <italic>B-RAF</italic><sup>V600E</sup> mutation according to tumor sites in the groups of outdoor and indoor workers.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Tumor site</th>
<th align="center" valign="bottom"><italic>B-RAF</italic><sup>V600E</sup> mutation</th>
<th align="center" valign="bottom">Outdoor<break/>n (&#x00025;)</th>
<th align="center" valign="bottom">Indoor<break/>n (&#x00025;)</th>
<th align="center" valign="bottom">P-value<xref rid="tfn2-or-31-03-1079" ref-type="table-fn">a</xref></th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Trunk</td>
<td align="center" valign="top">Yes</td>
<td align="center" valign="top">9 (47)</td>
<td align="center" valign="top">12 (85)</td>
<td align="center" valign="top">0.03</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">No</td>
<td align="center" valign="top">10 (53)</td>
<td align="center" valign="top">2 (15)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">Total</td>
<td align="center" valign="top">19</td>
<td align="center" valign="top">14</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">Head and neck</td>
<td align="center" valign="top">Yes</td>
<td align="center" valign="top">5 (42)</td>
<td align="center" valign="top">7 (78)</td>
<td align="center" valign="top">0.18</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">No</td>
<td align="center" valign="top">7 (58)</td>
<td align="center" valign="top">2 (22)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">Total</td>
<td align="center" valign="top">12</td>
<td align="center" valign="top">9</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">Limbs</td>
<td align="center" valign="top">Yes</td>
<td align="center" valign="top">6 (86)</td>
<td align="center" valign="top">3 (43)</td>
<td align="center" valign="top">0.26</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">No</td>
<td align="center" valign="top">1 (14)</td>
<td align="center" valign="top">4 (57)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">Total</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top">7</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">All sites</td>
<td align="center" valign="top">Yes</td>
<td align="center" valign="top">20 (52)</td>
<td align="center" valign="top">22 (73)</td>
<td align="center" valign="top">0.08</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">No</td>
<td align="center" valign="top">18 (48)</td>
<td align="center" valign="top">8 (27)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top"/>
<td align="center" valign="top">Total</td>
<td align="center" valign="top">38</td>
<td align="center" valign="top">30</td>
<td align="center" valign="top"/></tr></tbody></table>
<table-wrap-foot><fn id="tfn2-or-31-03-1079">
<label>a</label>
<p>Fisher&#x02019;s exact test, Two-tailed.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="tIII-or-31-03-1079" position="float">
<label>Table III</label>
<caption>
<p>Distribution of <italic>B-RAF</italic><sup>V600E</sup> mutation according to chronic exposure to sun and intermittent exposure to sun.<xref rid="tfn3-or-31-03-1079" ref-type="table-fn">a</xref></p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"><italic>B-RAF</italic><sup>V600E</sup> mutation</th>
<th align="center" valign="bottom">Chronic exposure to sun<break/>n (&#x00025;)</th>
<th align="center" valign="bottom">Intermittent exposure to sun<break/>n (&#x00025;)</th>
<th align="center" valign="bottom">P-value<xref rid="tfn4-or-31-03-1079" ref-type="table-fn">b</xref></th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">9 (16)</td>
<td align="center" valign="top">30 (47)</td>
<td align="center" valign="top">&lt;0.0001</td></tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">46 (84)</td>
<td align="center" valign="top">34 (53)</td>
<td align="center" valign="top"/></tr>
<tr>
<td align="left" valign="top">Total</td>
<td align="center" valign="top">55</td>
<td align="center" valign="top">64</td>
<td align="center" valign="top"/></tr></tbody></table>
<table-wrap-foot><fn id="tfn3-or-31-03-1079">
<label>a</label>
<p>Cosmic Catalogue of Mutations in Cancer analysis;</p></fn><fn id="tfn4-or-31-03-1079">
<label>b</label>
<p>Fisher&#x02019;s exact test, Two-tailed.</p></fn></table-wrap-foot></table-wrap></sec></back></article>
